 |
|
Effectiveness of inactivated hantavirus vaccine on the disease severity of hemorrhagic fever with renal syndrome
Yongjin Yi, Hayne Park, Jaehun Jung
Kidney Res Clin Pract. 2018;37(4):366-372. Published online 2018 Dec 31 DOI: https://doi.org/10.23876/j.krcp.18.0044
|
|
Citations to this article as recorded by
 Scientometric Analysis of Research Trends in Hemorrhagic Fever with Renal Syndrome: A Historical Review and Network Visualization
Bing Xu, Qian Yin, Danfeng Ren, Shaocong Mo, Tianzhi Ni, Shan Fu, Ze Zhang, Taotao Yan, Yingren Zhao, Jinfeng Liu, Yingli He
Journal of Infection and Public Health.2025; : 102647. CrossRef In silico design of multi-epitope vaccines against the hantaviruses by integrated structural vaccinology and molecular modeling approaches
Liaqat Ali, Sobiah Rauf, Abbas Khan, Samreen Rasool, Rabail Zehra Raza, Fahad M. Alshabrmi, Taimoor Khan, Muhammad Suleman, Yasir Waheed, Anwar Mohammad, Abdelali Agouni, Sheikh Arslan Sehgal
PLOS ONE.2024; 19(7): e0305417. CrossRef Hemorrhagic Fever with Renal Syndrome in Asia: History, Pathogenesis, Diagnosis, Treatment, and Prevention
Ayushi Sehgal, Sanya Mehta, Kritika Sahay, Ekaterina Martynova, Albert Rizvanov, Manoj Baranwal, Sara Chandy, Svetlana Khaiboullina, Emmanuel Kabwe, Yuriy Davidyuk
Viruses.2023; 15(2): 561. CrossRef Hantavirus in humans: a review of clinical aspects and management
Pablo A Vial, Marcela Ferrés, Cecilia Vial, Jonas Klingström, Clas Ahlm, René López, Nicole Le Corre, Gregory J Mertz
The Lancet Infectious Diseases.2023; 23(9): e371. CrossRef Immunogenic Properties of MVs Containing Structural Hantaviral Proteins: An Original Study
Layaly Shkair, Ekaterina Evgenevna Garanina, Ekaterina Vladimirovna Martynova, Alena Igorevna Kolesnikova, Svetlana Sergeevna Arkhipova, Angelina Andreevna Titova, Albert Anatolevich Rizvanov, Svetlana Francevna Khaiboullina
Pharmaceutics.2022; 14(1): 93. CrossRef The Clinical Characteristics and Outcomes of Hemorrhagic Fever With Renal Syndrome in Pregnancy
Danfeng Ren, Shan Fu, Taotao Yan, Tianzhi Ni, Ze Zhang, Mengmeng Zhang, Jingwen Zhou, Nan Yang, Yuan Yang, Yingli He, Tianyan Chen, Yingren Zhao, Jinfeng Liu
Frontiers in Medicine.2022;[Epub] CrossRef Design of a Multi-Epitopes Vaccine against Hantaviruses: An Immunoinformatics and Molecular Modelling Approach
Saba Ismail, Sumra Wajid Abbasi, Maha Yousaf, Sajjad Ahmad, Khalid Muhammad, Yasir Waheed
Vaccines.2022; 10(3): 378. CrossRef A Historical Review of Military Medical Strategies for Fighting Infectious Diseases: From Battlefields to Global Health
Roberto Biselli, Roberto Nisini, Florigio Lista, Alberto Autore, Marco Lastilla, Giuseppe De Lorenzo, Mario Stefano Peragallo, Tommaso Stroffolini, Raffaele D’Amelio
Biomedicines.2022; 10(8): 2050. CrossRef Hantavirus diseases pathophysiology, their diagnostic strategies and therapeutic approaches: A review
Naveed Munir, Muhammad Jahangeer, Shoukat Hussain, Zahed Mahmood, Mehvish Ashiq, Fatima Ehsan, Muhammad Akram, Syed Muhammad Ali Shah, Muhammad Riaz, Aneezah Sana
Clinical and Experimental Pharmacology and Physiology.2021; 48(1): 20. CrossRef Genomic Epidemiology and Active Surveillance to Investigate Outbreaks of Hantaviruses
Won-Keun Kim, Seungchan Cho, Seung-Ho Lee, Jin Sun No, Geum-Young Lee, Kyungmin Park, Daesang Lee, Seong Tae Jeong, Jin-Won Song
Frontiers in Cellular and Infection Microbiology.2021;[Epub] CrossRef Immune response during hantavirus diseases: implications for immunotherapies and vaccine design
Farides Saavedra, Fabián E. Díaz, Angello Retamal‐Díaz, Camila Covián, Pablo A. González, Alexis M. Kalergis
Immunology.2021; 163(3): 262. CrossRef Integrative Analysis of HTNV Glycoprotein Derived MHC II Epitopes by In Silico Prediction and Experimental Validation
Hao Sun, Zhenhua Lu, Guoyun Xuan, Ning Liu, Tianhu Wang, Yang Liu, Mingfu Lan, Jiahao Xu, Yuancai Feng, Shuang Xu, Yuchen Lu, Baozeng Sun, Jinpeng Zhang, Xiyang Zhang, Yuanjie Sun, Shuya Yang, Yun Zhang, Yusi Zhang, Linfeng Cheng, Dongbo Jiang, Kun Yang
Frontiers in Cellular and Infection Microbiology.2021;[Epub] CrossRef Vaccines and Therapeutics Against Hantaviruses
Rongrong Liu, Hongwei Ma, Jiayi Shu, Qiang Zhang, Mingwei Han, Ziyu Liu, Xia Jin, Fanglin Zhang, Xingan Wu
Frontiers in Microbiology.2020;[Epub] CrossRef Hantavirus Infections—Treatment and Prevention
Kalpa Dheerasekara, Saranga Sumathipala, Rohitha Muthugala
Current Treatment Options in Infectious Diseases.2020; 12(4): 410. CrossRef Biodefense Implications of New-World Hantaviruses
Michael Hilary D’Souza, Trushar R. Patel
Frontiers in Bioengineering and Biotechnology.2020;[Epub] CrossRef Protective CD8+ T-cell response against Hantaan virus infection induced by immunization with designed linear multi-epitope peptides in HLA-A2.1/Kb transgenic mice
Ying Ma, Kang Tang, Yusi Zhang, Chunmei Zhang, Linfeng Cheng, Fanglin Zhang, Ran Zhuang, Boquan Jin, Yun Zhang
Virology Journal.2020;[Epub] CrossRef Introduction of Vaccinomics to Develop Personalized Vaccines in Light of Changes in the Usage of Hantaan Virus Vaccine (Hantavax®) in Korea
Jong-Myon Bae
Journal of Preventive Medicine and Public Health.2019; 52(5): 277. CrossRef Progress on the Prevention and Treatment of Hantavirus Disease
Rebecca L. Brocato, Jay W. Hooper
Viruses.2019; 11(7): 610. CrossRef Epidemiological and time series analysis of haemorrhagic fever with renal syndrome from 2004 to 2017 in Shandong Province, China
Chao Zhang, Xiao Fu, Yuanying Zhang, Cuifang Nie, Liu Li, Haijun Cao, Junmei Wang, Baojia Wang, Shuying Yi, Zhen Ye
Scientific Reports.2019;[Epub] CrossRef
|